AEON
AMEX
$0.29
AEON Biopharma Inc - Class A (AEON)
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. The company is headquartered in Newport Beach, California.
Sector:
Healthcare
Industry:
Biotechnology
Target: $6.70 (+2246.76%)
Market Cap
$7.31M
Beta (5Y)
0.35
Price Chart
Valuation
Market Cap$7.31M
Forward P/E1.16
P/S97.16
Profitability
EBITDA-$18M
EPS-$4.50
Growth & Risk
Beta (5Y)0.35
Sharpe Ratio-0.50